Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

OBJECTIVE: To compare ultra-long-acting insulin degludec with glargine for efficacy and safety in insulin-naive patients with type 2 diabetes inadequately controlled with oral antidiabetic drugs (OADs). RESEARCH DESIGN AND METHODS: In this 1-year, parallel-group, randomized, open-label, treat-to-tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zinman, Bernard, Philis-Tsimikas, Athena, Cariou, Bertrand, Handelsman, Yehuda, Rodbard, Helena W., Johansen, Thue, Endahl, Lars, Mathieu, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507614/
https://www.ncbi.nlm.nih.gov/pubmed/23043166
http://dx.doi.org/10.2337/dc12-1205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507614/
https://www.ncbi.nlm.nih.gov/pubmed/23043166
http://dx.doi.org/10.2337/dc12-1205

Ejemplares similares